KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Minority Interest (2016 - 2025)

Historic Minority Interest for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $81.0 million.

  • Quest Diagnostics' Minority Interest rose 125.0% to $81.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.0 million, marking a year-over-year increase of 125.0%. This contributed to the annual value of $83.0 million for FY2024, which is 921.05% up from last year.
  • As of Q3 2025, Quest Diagnostics' Minority Interest stood at $81.0 million, which was up 125.0% from $81.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Minority Interest ranged from a high of $83.0 million in Q4 2024 and a low of $76.0 million during Q3 2023
  • Moreover, its 5-year median value for Minority Interest was $78.0 million (2021), whereas its average is $78.5 million.
  • As far as peak fluctuations go, Quest Diagnostics' Minority Interest crashed by 365.85% in 2021, and later soared by 921.05% in 2024.
  • Quarter analysis of 5 years shows Quest Diagnostics' Minority Interest stood at $79.0 million in 2021, then fell by 2.53% to $77.0 million in 2022, then dropped by 1.3% to $76.0 million in 2023, then rose by 9.21% to $83.0 million in 2024, then dropped by 2.41% to $81.0 million in 2025.
  • Its Minority Interest was $81.0 million in Q3 2025, compared to $81.0 million in Q2 2025 and $81.0 million in Q1 2025.